In response to emergent antibiotic resistance, new strategies are needed to enhance the effectiveness of existing antibiotics. Here, we describe a phagemid-delivered, RNA-mediated system capable of directly knocking down antibiotic resistance phenotypes. Small regulatory RNAs (sRNAs) were designed to specifically inhibit translation of chloramphenicol acetyltransferase and kanamycin phosphotransferase. Nonlytic phagemids coding for sRNA expression were able to infect and restore chloramphenicol and kanamycin sensitivity to populations of otherwise resistant E. coli. This modular system could easily be extended to other bacteria with resistance profiles that depend on specific transcripts.
Nuclease bacteriocins are potential antimicrobials for the treatment of antibiotic-resistant bacterial infections. While the mechanism of outer membrane translocation is beginning to be understood, the mechanism of inner membrane transport is not known.
Bacteriocins of Gram-negative bacteria are typically multi-domain proteins that target and kill bacteria of the same or closely related species. There is increasing interest in protein bacteriocin import; from a fundamental perspective to understand how folded proteins are imported into bacteria and from an applications perspective as species-specific antibiotics to combat multidrug resistant bacteria. In order to translocate across the cell envelope and cause cell death, protein bacteriocins hijack nutrient uptake pathways. Their import is energized by parasitizing intermembrane protein complexes coupled to the proton motive force, which delivers a toxic domain into the cell. A plethora of genetic, structural, biochemical, and biophysical methods have been applied to find cell envelope components involved in bacteriocin import since their discovery almost a century ago. Here, we review the various approaches that now exist for investigating how protein bacteriocins translocate into Gram-negative bacteria and highlight areas of research that will need methodological innovations to fully understand this process. We also highlight recent studies demonstrating how bacteriocins can be used to probe organization and architecture of the Gram-negative cell envelope itself.
Bioremediation is promising technology for dealing with oil hydrocarbons
contamination. In this research growth kinetics and oil biodegradation
efficiency of Pseudomonas luteola PRO23, isolated from crude oil-contaminated
soil samples, were investigated under different concentrations (5, 10 and 20
g/L) of light and heavy crude oil. More efficient biodegradation and more
rapid adaptation and cell growth were obtained in conditions with light oil.
The 5 to 10 g/L upgrade of light oil concentration stimulated the microbial
growth and the biodegradation efficiency. Further upgrade of light oil
concentration and the upgrade of heavy oil concentration both inhibited the
microbial growth, as well as biodegradation process. Aminoglycosides
stimulated biosurfactant production in P. luteola in the range of
sub-inhibitory concentrations (0.3125, 0.625 ?g/mL). Aminoglycosides also
induced biofilm formation. The production of biosurfactants was the most
intense during lag phase and continues until stationary phase.
Aminoglycosides also induced changes in P. luteola growth kinetics. In the
presence of aminoglycosides this strain degraded 82% of diesel for 96 h.
These results indicated that Pseudomonas luteola PRO23 potentially can be
used in bioremediation of crude oil-contaminated environments and that
aminoglycosides could stimulate this process. [Projekat Ministarstva nauke
Republike Srbije, br. TR31080]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.